The association of Gal-1 with more orderly structural healing and decreased ventricular dilatation in experimental models of myocardial infarction may be beneficial, as Gal-1 opposes profibrotic mechanisms and slows substrate formation. Here, LGALS1 is linked to Ventriculomegaly.